Financhill
Sell
40

DHI Quote, Financials, Valuation and Earnings

Last price:
$146.64
Seasonality move :
5.63%
Day range:
$143.73 - $147.20
52-week range:
$110.44 - $184.55
Dividend yield:
1.13%
P/E ratio:
12.64x
P/S ratio:
1.33x
P/B ratio:
1.77x
Volume:
997K
Avg. volume:
3.1M
1-year change:
3.96%
Market cap:
$42.8B
Revenue:
$34.3B
EPS (TTM):
$11.60

Earnings Data

Next earnings date for DHI
Jan 20
2026
Most recent earnings per share
$3.04
Missed by $0.23
(Oct 28/2025)
Consensus Estimate
$3.27
(Oct 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DHI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/20/2026 Q4 $6.7B -- -- $1.95 --
10/28/2025 Q3 $9.4B $9.7B $3.04 $3.27 -$0.23
07/22/2025 Q2 $8.8B $9.2B $3.36 $2.90 $0.46
04/17/2025 Q1 $8B $7.7B $2.58 $2.70 -$0.12
01/21/2025 Q4 $7.1B $7.6B $2.61 $2.36 $0.26
10/29/2024 Q3 $10.2B $10B $3.92 $4.17 -$0.25
07/18/2024 Q2 $9.6B $10B $4.10 $3.78 $0.32
04/18/2024 Q1 $8.2B $9.1B $3.52 $3.07 $0.45
01/23/2024 Q4 $7.6B $7.7B $2.82 $2.88 -$0.05
11/07/2023 Q3 -- $10.5B $4.45 -- --
07/20/2023 Q2 -- $9.7B $3.90 -- --
04/20/2023 Q1 -- $8B $2.73 -- --
01/24/2023 Q4 -- $7.3B $2.76 -- --
11/09/2022 Q3 -- $9.6B $4.67 -- --
07/21/2022 Q2 -- $8.8B $4.67 -- --
04/26/2022 Q1 -- $8B $4.03 -- --
02/02/2022 Q4 -- $7.1B $3.17 -- --
11/09/2021 Q3 -- $8.1B $3.70 -- --
07/22/2021 Q2 -- $7.3B $3.06 -- --
04/22/2021 Q1 -- $6.4B $2.53 -- --
01/26/2021 Q4 -- $5.9B $2.14 -- --
11/10/2020 Q3 -- $6.4B $2.24 -- --
07/28/2020 Q2 -- $5.4B $1.72 -- --
04/28/2020 Q1 -- $4.5B $1.30 -- --
01/27/2020 Q4 -- $4B $1.16 -- --
11/12/2019 Q3 -- $5B $1.35 -- --
07/30/2019 Q2 -- $4.9B $1.26 -- --
04/25/2019 Q1 -- $4.1B $0.93 -- --
01/25/2019 Q4 -- $3.5B $0.76 -- --
11/08/2018 Q3 -- $4.5B $1.22 -- --
07/26/2018 Q2 -- $4.4B $1.18 -- --
04/26/2018 Q1 -- $3.8B $0.91 -- --
01/31/2018 Q4 -- $3.3B $0.49 -- --
11/09/2017 Q3 -- $4.2B $0.82 -- --
07/26/2017 Q2 -- $3.8B $0.76 -- --
04/20/2017 Q1 -- $3.3B $0.60 -- --
01/24/2017 Q4 -- $2.9B $0.55 -- --
11/08/2016 Q3 -- $3.7B $0.75 -- --
07/21/2016 Q2 -- $3.2B $0.66 -- --
04/21/2016 Q1 -- $2.8B $0.52 -- --
01/25/2016 Q4 -- $2.4B $0.42 -- --

D.R. Horton, Inc. Earnings Questions

  • How Much did D.R. Horton, Inc. Generate in Revenue Last Quarter?

    D.R. Horton, Inc. reported $9.7B worth of top line sales in its most recent quarter.

  • Did D.R. Horton, Inc. Beat Earnings Last Quarter?

    D.R. Horton, Inc. announced earnings per share of $3.04 which represents a miss of analyst forecast a $3.27 per share.

  • Is D.R. Horton, Inc. Profitable?

    D.R. Horton, Inc. reported $2.1B that represents $7.05 per share over the last quarter.

  • What is the Analyst Consensus for D.R. Horton, Inc. EPS Next Year?

    D.R. Horton, Inc.'s earnings are forecast to decrease from $11.57 per share to $11.81 per share next year representing a decrease of -1.56%.

  • When is D.R. Horton, Inc.'s Earnings Date?

    D.R. Horton, Inc.'s next earnings date is January 20, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock